Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1985 Jun;142(6):810–813.

Managing patients who have myasthenia gravis.

T R Johns 2nd
PMCID: PMC1306184  PMID: 4024633

Full text

PDF
810

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Mertens H. G., Hertel G., Reuther P., Ricker K. Effect of immunosuppressive drugs (azathioprine). Ann N Y Acad Sci. 1981;377:691–699. doi: 10.1111/j.1749-6632.1981.tb33767.x. [DOI] [PubMed] [Google Scholar]
  2. Pascuzzi R. M., Coslett H. B., Johns T. R. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol. 1984 Mar;15(3):291–298. doi: 10.1002/ana.410150316. [DOI] [PubMed] [Google Scholar]
  3. Perlo V. P., Arnason B., Poskanzer D., Castleman B., Schwab R. S., Osserman K. E., Papatestis A., Alpert L., Kark A. The role of thymectomy in the treatment of myasthenia gravis. Ann N Y Acad Sci. 1971 Sep 15;183:308–315. doi: 10.1111/j.1749-6632.1971.tb30761.x. [DOI] [PubMed] [Google Scholar]
  4. Sghirlanzoni A., Peluchetti D., Mantegazza R., Fiacchino F., Cornelio F. Myasthenia gravis: prolonged treatment with steroids. Neurology. 1984 Feb;34(2):170–174. doi: 10.1212/wnl.34.2.170. [DOI] [PubMed] [Google Scholar]
  5. Simpson J. A. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2. Muscle Nerve. 1978 Mar-Apr;1(2):151–156. doi: 10.1002/mus.880010208. [DOI] [PubMed] [Google Scholar]
  6. Witte A. S., Cornblath D. R., Parry G. J., Lisak R. P., Schatz N. J. Azathioprine in the treatment of myasthenia gravis. Ann Neurol. 1984 Jun;15(6):602–605. doi: 10.1002/ana.410150615. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES